CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 20 enrolled
Drug / intervention
Hyperinsulinemic Hypoglycemic Clampother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00574340
NCT00574340Early Ph 1Completed
CompareCT.gov

SCCOR in Hemostatic and Thrombotic Diseases Project 5 - Metabolic Causes of Thrombosis in Type 2 Diabetes

University of Maryland, Baltimore·interventional·Posted Dec 17, 2007·Updated Sep 12, 2019

In Brief

A Early Phase 1 clinical trial evaluating Hyperinsulinemic Hypoglycemic Clamp for Type 2 Diabetes. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Hypoglycemia (low blood glucose level) occurs frequently in intensively treated patients with diabetes. Although hypoglycemia was thought to occur almost exclusively in T1DM, with the advent of improved metabolic control in T2DM, the incidence of hypoglycemia is rising in these patients. Therefore in this application, we will test the novel hypothesis that prior hypoglycemia will result in (cardiovascular complications) during subsequent hypoglycemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Early Ph 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 17, 2007
Enrollment StartMay 1, 2007
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 18.5 years ago

Interventions

Hyperinsulinemic Hypoglycemic Clampother

all participants received (2) hyperinsulinemic glucose clamp studies separated by 8 weeks